Combined Effect of Tryptophan Rich Diet and Acupuncture on Depression Related to Premenstrual Dysphoric Disorder
NCT05813366 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39
Last updated 2023-04-14
Summary
Premenstrual Dysphoric Disorder (PMDD) is a severe form of premenstrual syndrome (PMS) affecting up to 8% of reproductive age women. It is characterized by physical and psychological symptoms that occur in the luteal phase of the menstrual cycle, prior to the onset of menses, and leads to negative impact on the psychosocial functioning of affected individuals.
Selective serotonin reuptake inhibitors are usually used to treat PMDD but they have several side effects so it is important to use complementary treatment such as tryptophan-rich diet and acupuncture for women with PMDD . The purpose of the current study is to determine the combined effect of tryptophan-rich diet and acupuncture on depression related to premenstrual dysphoric disorder
Conditions
- Premenstrual Dysphoric Disorder
Interventions
- OTHER
-
Acupuncture
Tony disposable, single-use 0.20×40 mm Chinese needles will be used. The needle penetrates the skin sufficiently to reach the required depth and elicit de qi. The needles remains for 30 min, with gentle rotational movements applied three times during the session.
- OTHER
-
Tryptophan-Rich Diet
All participants in both groups (A and C) will be treated by high protein foods rich with tryptophan including: chicken , turkey, red meat, salmon, fish, tuna, beans, milk, cheese, seeds, nuts, egg, banana, kiwi, leafy greens, mushroom, broccoli and peas, etc. Total daily calorie intake will be calculated for each participant in both groups (A and C) before diet description. All females will serve the meals that met their required kilocalorie levels and physical activity levels so that the participants will not lose weight, feel hungry or be over-fed.
- OTHER
-
Vitamin B6 Supplementation
All participants in all groups (A, B and C) will receive a tablet of vitamin B6 60mg once/day for 8 weeks, starting from the first day of their menstrual cycle, throughout two menstrual cycles.
Sponsors & Collaborators
-
Cairo University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 30 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-04-25
- Primary Completion
- 2023-06-25
- Completion
- 2023-07-25
More Related Trials
-
Depressive Symptoms and Subjective Stress in the Course of the Menstrual Cycle - an Ambulatory Assessment Study.
NCT04086316 ·Status: COMPLETED
-
Emotional Processing and Oxytocin Mechanisms in Premenstrual Dysphoric Disorder: A Pilot Study
NCT02508103 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Premenstrual Syndrome and Premenstrual Dysphoria
NCT00001177 ·Status: COMPLETED
-
Estrogen and Serotonin on Changing Brain Chemistry
NCT01208324 ·Status: COMPLETED ·Phase: NA
-
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
NCT05282277 ·Status: RECRUITING ·Phase: PHASE4
-
A Treatment Study for Premenstrual Syndrome (PMS)
NCT00001259 ·Status: COMPLETED ·Phase: PHASE1
-
Combined Hormone Replacement in Menstrually-Related Mood Disorders
NCT00005011 ·Status: COMPLETED
-
Sleep and Light Intervention (SALI) for Menopausal Mood Dysfunction
NCT06678880 ·Status: RECRUITING ·Phase: NA
-
Impact of Hot Flashes on Sleep and Mood Disturbance
NCT01116401 ·Status: COMPLETED ·Phase: PHASE4
-
Progestin (Progesterone-Like Hormones) Induced Dysphoria (Depressed Mood, Irritability, Anxiety)
NCT00001770 ·Status: COMPLETED
-
Hormonal Causes of Menstrual-Related Mood Disorders
NCT00100360 ·Status: COMPLETED
-
Melatonin Use in Patients With Climacterious Symptoms in the Perimenopause
NCT06192641 ·Status: COMPLETED ·Phase: PHASE2
-
Therapeutic Effect of Laser Acupuncture on Insomnia in Perimenopausal Women
NCT04000113 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Different Psychiatric Symptoms in Patients With Thyroid Dysfunction
NCT06185309 ·Status: NOT_YET_RECRUITING
-
Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model
NCT04051320 ·Status: COMPLETED ·Phase: PHASE2
-
Biochemical Brain Changes Correlated With The Antidepressant Effect Of Thyroid Hormones
NCT00562367 ·Status: COMPLETED ·Phase: NA
-
Dopamine, Reward Learning and Sex Hormones
NCT06365515 ·Status: RECRUITING ·Phase: NA
-
Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder
NCT00626340 ·Status: COMPLETED ·Phase: PHASE4
-
Estrogen and Perimenopausal Depression
NCT00229450 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Depression and Sleep Disorders in Endometriosis Patients
NCT04009902 ·Status: COMPLETED
-
The Effect of GnRH on Pitutitary Hormones in Menstrual-Cycle Mood Related Disorders
NCT00001232 ·Status: COMPLETED
-
Circadian Rhythm Dysregulation in Offspring of Parents With Bipolar Disorder
NCT03656302 ·Status: UNKNOWN
-
Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women
NCT00530582 ·Status: COMPLETED ·Phase: PHASE4
-
Melatonin Effects on Luteinizing Hormone
NCT00288262 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Identification and Validation of Epigenetic Biomarkers of PMDD
NCT06771583 ·Status: RECRUITING